Hypothesis: Paroxetine, a G Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor Reduces Morbidity and Mortality in Patients With Heart Failure.
Faculty Articles
Part of the Pharmacy and Pharmaceutical Sciences Commons
Part of the Pharmacy and Pharmaceutical Sciences Commons